GC Wealth Management RIA’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Sell
39,089
-2,448
-6% -$287K 0.29% 71
2026
Q1
$5M Sell
41,537
-2,540
-6% -$293K 0.21% 75
2025
Q4
$4.64M Sell
44,077
-22,336
-34% -$2.1M 0.17% 83
2025
Q3
$5.57M Buy
66,413
+43,836
+194% +$3.61M 0.18% 96
2025
Q2
$1.79M Sell
22,577
-6,400
-22% -$509K 0.15% 145
2025
Q1
$2.6M Buy
28,977
+1,230
+4% +$115K 0.48% 50
2024
Q4
$2.76M Buy
27,747
+6,284
+29% +$648K 0.49% 46
2024
Q3
$2.44M Buy
21,463
+3,731
+21% +$443K 0.43% 53
2024
Q2
$2.2M Buy
17,732
+672
+4% +$86.6K 0.43% 49
2024
Q1
$2.25M Buy
17,060
+6,522
+62% +$804K 0.45% 41
2023
Q4
$1.15M Buy
+10,538
New +$1.09M 0.52% 50

Other funds holding MRK

GC Wealth Management RIA's MRK Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Merck (MRK) stake by 5.9% in Q2 2026, selling an estimated $287K and leaving 39,089 shares worth $5.02M. The position accounts for 0.29% of the portfolio, ranked #71.

GC Wealth Management RIA first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.57M in Q3 2025. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GC Wealth Management RIA held 39,089 shares of Merck worth $5.02M as of Q2 2026.
  • GC Wealth Management RIA sold 2,448 Merck shares in Q2 2026, an estimated $287K.
  • Merck made up 0.29% of GC Wealth Management RIA's portfolio in Q2 2026, its #71 holding.
  • GC Wealth Management RIA first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • GC Wealth Management RIA's Merck position peaked at $5.57M in Q3 2025.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.